Saltar al contenido
Merck

HIL18MAG-66K

Kit de microesferas magnéticas uniplex para IL-18 humana MILLIPLEX®

Human IL-18 Singleplex Kit

Sinónimos:

Ensayo microesferas magnéticas

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

NACRES:
NA.84
UNSPSC Code:
12161503
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


Nombre del producto

Kit de microesferas magnéticas uniplex para IL-18 humana MILLIPLEX®,

description

Human IL-18 Singleplex Kit

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

technique(s)

multiplexing: suitable

input

cell culture supernatant(s)
plasma
serum

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Interleukin-18 (IL-18) is a pro-inflammatory cytokine that plays a crucial role in the immune response by promoting the activation and proliferation of T cells and natural killer (NK) cells. It is primarily produced by macrophages and dendritic cells and is involved in various physiological processes, including inflammation, infection, and autoimmune diseases. Elevated levels of IL-18 have been associated with several conditions, such as cardiovascular diseases, cancer, and chronic inflammatory disorders, making it an important biomarker for research and therapeutic targets.

Application

MILLIPLEX® Qualified assays undergo rigourous assay development, verification, and Quality Control testing to achieve optimal performance. Analyze IL-18 in human serum, plasma, and cell culture supernatants.

Analytes included: IL-18

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Facilitates Biomarker Discovery: Useful in studying diseases where IL-18 plays a role, such as autoimmune disorders, infections, and cancer.
  • User-Friendly: The straightforward protocol makes it accessible even for labs with limited experience in cytokine assays.
  • Multiplexing Flexibility: The IL-18 kit can be combined with other MILLIPLEX® kits, allowing for the simultaneous measurement of multiple cytokines and biomarkers in a single sample.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Clase de almacenamiento

10 - Combustible liquids

wgk

WGK 3



Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Chuanhai Cao et al.
Frontiers in aging neuroscience, 14, 829049-829049 (2022-05-20)
The immune system plays a critical role in the development and progression of Alzheimer's disease (AD). However, there is disagreement as to whether development/progression of AD involves an over-activation or an under-activation of the immune system. In either scenario, the
Gyoung Nyoun Kim et al.
PLoS pathogens, 17(12), e1010092-e1010092 (2021-12-17)
The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV genomes



Número de artículo de comercio global

SKUGTIN
HIL18MAG-66K04054839535499